| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |